Analysis of Molecular Changes and Treatment Options for Thymic Epithelial Tumors in Adults

What this Trial Is About

Thymic malignancies, including thymic epithelial tumors and carcinomas, are the most common tumors in the front part of the chest. While surgery and radiation can often treat these cancers, some cases continue to worsen and can be fatal. Researchers recognize the urgent need to better understand molecular changes in these tumors to predict how patients will respond to new targeted treatments and improve survival outcomes. This project is an observational study aiming to build a registry of patients with thymic malignancies to analyze their genetic alterations. Based on molecular analysis, different chemotherapy treatments may be evaluated. The study is focused on characterizing these molecular changes and exploring novel treatment approaches tailored to individual tumor profiles. Participants will be followed for up to 20 years to measure outcomes such as objective response rate, disease control rate, and progression-free survival. Overall survival will also be assessed. Throughout the study, patient information and treatment responses will be collected to advance molecular diagnostics and individualized care for thymic malignancies.

Molecular Analysis and Treatment Options of Thymic Malignancies